XML 14 R4.htm IDEA: XBRL DOCUMENT v3.20.2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Income Statement [Abstract]        
Net Sales $ 15,280 $ 15,407 $ 47,033 $ 45,812
Cost of Sales 14,934 15,424 44,693 44,085
Gross Profit 346 (17) 2,340 1,727
Selling and Marketing 1,669 1,827 5,738 7,149
General and Administrative 3,622 4,623 11,767 16,341
Settlement Expense 0 0 0 430
Research and Product Development 1,745 1,475 5,183 4,930
Operating Loss (6,690) (7,942) (20,348) (27,123)
Other Income (Expense)        
Realized Gain on Investments 4 6 8 24
Warrant Modification Expense 0 0 (837) 0
Interest Expense (666) (16) (1,289) (16)
Interest Income 2 97 239 289
Total Other Income (Expense) (660) 87 (1,879) 297
Net Loss $ (7,350) $ (7,855) $ (22,227) $ (26,826)
Basic and diluted net loss per share (in dollars per share) $ (100) $ (120) $ (320) $ (450)
Basic and diluted weighted average shares outstanding (in shares) 71,811,322,000 63,796,723,000 69,594,167,000 59,728,446,000